On April 28, 2023 Kazia Therapeutics, an oncologyf ocused drug development company, reported an update on the ongoing development of its product candidates for the quarter ending 31 March 2023 (Press release, Kazia Therapeutics, APR 28, 2023, View Source [SID1234633086]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!